CLYM · Climb Bio, Inc.

$17.70 +0.68 (+3.97%)

Market Cap

$977.57M

57.44M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-14	2026-08-13
8-K	2026-08-06	—
10-Q	2026-08-06	2026-06-30
8-K	2026-07-01	2026-06-29
8-K	2026-06-12	2026-06-11
8-K	2026-06-11	—
8-K	2026-06-08	2026-06-05
8-K	2026-06-05	—
Investor Event Transcript	2026-06-04	2026-06-30
Investor Event Transcript	2026-06-04	2026-06-30
Investor Event Transcript	2026-05-19	2026-06-30
8-K	2026-05-07	—
10-Q	2026-05-07	2026-03-31
8-K	2026-05-05	—
8-K	2026-04-28	2026-04-27
DEF 14A	2026-04-24	2026-06-05
8-K	2026-04-03	2026-04-01
10-K	2026-03-05	2025-12-31
8-K	2026-03-05	—
8-K	2026-01-08	—
8-K	2025-12-31	—
8-K	2025-12-11	—
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	—
8-K	2025-10-17	—
8-K	2025-10-01	2025-09-30
8-K	2025-09-29	—
10-Q	2025-08-12	2025-06-30
8-K	2025-08-12	—
8-K	2025-06-18	2025-06-12
8-K	2025-06-05	2025-06-04
8-K	2025-05-23	—
10-Q	2025-05-14	2025-03-31
8-K	2025-05-14	—
DEF 14A	2025-04-25	2025-06-04
8-K	2025-04-01	2025-03-27
10-K	2025-03-25	2024-12-31
8-K	2025-03-25	—
8-K	2025-01-10	2025-01-08
8-K	2024-11-12	—
10-Q	2024-11-12	2024-09-30
8-K	2024-10-15	—
8-K	2024-10-02	—
8-K	2024-08-27	2024-08-23
8-K	2024-08-26	—
10-Q	2024-08-14	2024-06-30
8-K	2024-08-14	—
8-K	2024-06-27	—
8-K	2024-06-26	—
8-K	2024-06-12	—

Showing 1–50 of 91 filings

Key facts CIK 1768446 CUSIP 28658R106 13F (30d) 107 filings 107 filers Visit website Investor relations